Edwards Lifesciences Scraps $945 Million JenaValve Acquisition After FTC Secures Court Injunction
- January 16, 2026
The U.S. District Court for the District of Columbia granted the Federal Trade Commission’s (FTC’s) request for a preliminary injunction blocking Edwards Lifesciences Corp. from moving ahead with its acquisition of JenaValve Technology.
ARTICLE TAGS
You must be logged in to access this content.